Literature DB >> 10499540

Proglucagon processing profile in canine L cells expressing endogenous prohormone convertase 1/3 and prohormone convertase 2.

A B Damholt1, A M Buchan, J J Holst, H Kofod.   

Abstract

The tissue-specific differential processing of proglucagon (Pg) yields glucagon in pancreatic A cells and glucagon-like peptide-1 (GLP-1), GLP-2, and glicentin in intestinal L cells. It has been suggested that the difference in Pg cleavage in A and L cells is due to the presence of distinct prohormone convertases (PC) in the two cell types, PC1/3 in the L cell and PC2 in the A cell. PC2 has been shown to cleave the N-terminal part of Pg, being essential for glucagon formation and PC1/3 to cleave the C-terminal part of Pg, leading to the formation of GLP-1. However, some of the cleavage sites in Pg have not proven to be substrates exclusively for either PC2 or PC1/3, and the cleavage profile of Pg in a primary cultured L cell has not yet been correlated with the actual presence of PC2 and PC1/3 in the L cell. We demonstrate here the presence of PC1/3, PC2, and the PC2 chaperone 7b2, in L cells using light immunohistochemistry on sections from canine ileum and on a canine intestinal cell culture enriched for L cells. Analysis of the cultured L cells, using gel chromatography and RIA, confirms the classical intestinal cleavage profile of Pg, resulting in mainly glicentin, oxyntomodulin, GLP-1-(7-37), and GLP-2. Despite the presence of 7b2 and mature PC2, as demonstrated by Western blot, absolute minimal amounts of glucagon were detected. These data show that the presence of intracellular PC2 and 7b2 in a primary cell possessing Pg does not have to lead to the formation of glucagon. This formation must then require an additional element to occur, or alternatively, the results could be explained by a canine specific organization of PC2 and Pg into separate compartments, which would prevent interaction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10499540     DOI: 10.1210/endo.140.10.7068

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  12 in total

Review 1.  Gastrointestinal hormones regulating appetite.

Authors:  Owais Chaudhri; Caroline Small; Steve Bloom
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

2.  Two dipolar α-helices within hormone-encoding regions of proglucagon are sorting signals to the regulated secretory pathway.

Authors:  Leonardo Guizzetti; Rebecca McGirr; Savita Dhanvantari
Journal:  J Biol Chem       Date:  2014-04-11       Impact factor: 5.157

Review 3.  The Gut as an Endocrine Organ: Role in the Regulation of Food Intake and Body Weight.

Authors:  Audrey Melvin; Carel W le Roux; Neil G Docherty
Journal:  Curr Atheroscler Rep       Date:  2016-08       Impact factor: 5.113

4.  Oleanolic acid derivative DKS26 exerts antidiabetic and hepatoprotective effects in diabetic mice and promotes glucagon-like peptide-1 secretion and expression in intestinal cells.

Authors:  Fei-Fei Chen; Jian-Ta Wang; Li-Xia Zhang; Shu-Fang Xing; Yun-Xia Wang; Kai Wang; Shu-Li Deng; Ji-Quan Zhang; Lei Tang; Hao-Shu Wu
Journal:  Br J Pharmacol       Date:  2017-07-26       Impact factor: 8.739

Review 5.  Gut hormones, and short bowel syndrome: the enigmatic role of glucagon-like peptide-2 in the regulation of intestinal adaptation.

Authors:  G-R Martin; P-L Beck; D-L Sigalet
Journal:  World J Gastroenterol       Date:  2006-07-14       Impact factor: 5.742

6.  Insulin-secreting L-cells for the treatment of insulin-dependent diabetes.

Authors:  Heather Bara; Athanassios Sambanis
Journal:  Biochem Biophys Res Commun       Date:  2008-04-10       Impact factor: 3.575

7.  Pax6 regulates the proglucagon processing enzyme PC2 and its chaperone 7B2.

Authors:  Liora S Katz; Yvan Gosmain; Eric Marthinet; Jacques Philippe
Journal:  Mol Cell Biol       Date:  2009-02-17       Impact factor: 4.272

Review 8.  PCSK1 Variants and Human Obesity.

Authors:  B Ramos-Molina; M G Martin; I Lindberg
Journal:  Prog Mol Biol Transl Sci       Date:  2016-01-29       Impact factor: 3.622

9.  Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency.

Authors:  Robert S Jackson; John W M Creemers; I Sadaf Farooqi; Marie-Laure Raffin-Sanson; Andrea Varro; Graham J Dockray; Jens J Holst; Patricia L Brubaker; Pierre Corvol; Kenneth S Polonsky; Diane Ostrega; Kenneth L Becker; Xavier Bertagna; John C Hutton; Anne White; Mehul T Dattani; Khalid Hussain; Stephen J Middleton; Thomasina M Nicole; Peter J Milla; Keith J Lindley; Stephen O'Rahilly
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

Review 10.  Proglucagon-Derived Peptides as Therapeutics.

Authors:  Ryan A Lafferty; Finbarr P M O'Harte; Nigel Irwin; Victor A Gault; Peter R Flatt
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-18       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.